Approvals & regulatory · first seen 30m ago, updated 30m ago
Pharma industry asks FDA for more details on when one trial is enough
Pharmaceutical companies and industry groups are calling on the FDA to provide more details and examples about when sponsors can rely on one pivotal trial plus confirmatory evidence for a new drug’s approval. The push ...
Summary from Endpoints News.